Oh, the nuances of the “free market” economy… and the convoluted principles of economics.
One of the fundamental rules of free market economy is the law of supply and demand. If there is a high demand for a product then the price of that product rises as the supply is depleted, artificially or otherwise.
The funny thing is: the Indian market of hepatitis C patients is very large so why is the price of the drug plunging there, and is much cheaper by 99.57% than in the United States?
Recently, Bloomberg reported,
“Outsiders don’t want their daughters to marry any local boys, according to the village elders swapping stories in a tailor’s shop behind the Sikh temple, because most residents are infected with black jaundice.
That’s what they call hepatitis C, which is so common in parts of India’s Punjab state that the tailor-shop gossips might not be off base in their estimate. But prevalence could be something of an advantage these days. Drugmakers have made the village of Lande Rode one of the theaters in a battle to grab market share for sofosbuvir, a miracle cure that Gilead Sciences Inc. sells in the U.S. as Sovaldi at a retail price of $1,000 a pill. Gilead licensed 11 Indian companies to make generic versions, and they sealed marketing deals with others. Competition has been so fierce it’s driven down the cost and spurred thousands to be tested.
Manufacturers “want more and more patients” and are willing to wheel and deal on price, said Nirmaljeet Malhi, a gastroenterologist at Apollo Hospitals in Ludhiana, about 200 kilometers (124 miles) from Lande Rode. “If one agrees to it, the others will also have to. It’s a race where one cannot say no — because then they’re going to lose the business.”
The companies sponsor screening drives, hand out free test kits to hospitals and offer bulk discounts to entire villages. Sofosbuvir was cheap by most any standard when it hit the market in Punjab at $10 in March. Then the cost kept dropping, to as low as $4.29, and doctors predict it will continue to fall.”
Is it really about the size of disposable incomes? Or, is it about the drugmakers clout on the government?
India has been running after healthcare malpractices for years. In fact, it has filed charges against Nestle for putting lead into Maggi recently.
US lawmakers, on the other hand, are trying to blackmail public schools with threats of defunding if their schoolchildren are not properly vaccinated.
And this is not just about selling drugs and making a huge profit. It’s about keeping the next generations docile and malleable.
The control of Big Pharma in the US government and the World Health Organization can best be illustrated by a policy called “revolving door”, like so:
“Former CDC Director Now President of Merck’s Vaccine Unit
In the summer of 2011, Merck president Julie Gerberding said in a news interview1 that she’s “very bullish on vaccines,” as she recounted the various ways she helps Merck sell its products. What she didn’t divulge was her motivation for leaving her job as director of the Centers for Disease Control and Prevention (CDC)—an agency charged with overseeing vaccines and drug companies—and join Merck in the first place, back in January 2010.
If you don’t see the enormity of the influence her former high-level ties to the CDC can have, just consider the fact that Merck makes 14 of the 17 pediatric vaccines recommended by the CDC, and 9 of the 10 recommended for adults, and while vaccine safety advocates are trying to rein in the number of vaccines given to babies, safety concerns keep falling on deaf ears. The vaccine industry is booming, and it’s become quite clear that profit potential is the driving factor behind it.
One of the reasons for this is because vaccine patents do not expire like drugs do, so each vaccine adopted for widespread use has the potential to make enormous, continuous profits for decades to come. Vaccine makers also enjoy a high degree of immunity against lawsuits—and in the case of pandemic vaccines, absolute immunity—so the financial liability when something goes wrong is very low, compared to drugs.
Gerberding has a Long History of Disregard for Vaccine Safety
Joining a parade of other high-ranking government officials who pass through the revolving doors between government and Big Pharma, Gerberding left a trail of controversy behind her when she left the CDC. While a 2009 article by the Institute for Southern Studies lists a number of them2, I believe they left out the most important ones, namely her misinformation campaign about the pandemic swine flu vaccine, as well as her naive stance on vaccine safety issues in general.
The CDC disseminated extremely exaggerated data on the 2009 H1N1 “pandemic” and urged almost everyone in the U.S. to take the new, untested vaccines. When questions arose, they blocked CBS’s requests for samples of the swine flu cases and added obstacles to getting information. Despite the many dangers that have since been linked to the hastily developed vaccine—including the confirmed link to narcolepsy—the H1N1 vaccine is now part and parcel of the “regular” seasonal flu vaccine, although most people are completely unaware of this fact. And the CDC is now, for the first time ever, urging the seasonal flu vaccine on everyone in the country, from six months’ of age until death.
Even more disturbing, the CDC withheld data on miscarriages from the H1N1 vaccines under Gerberding’s lead, while insisting that pregnant women be put first in line to receive it. This was a dramatic reversal of its own recommendations. More than 3,500 post-vaccination miscarriages may have simply been ignored by the CDC.
One of Merck’s potentially most dangerous vaccines right now is Gardasil; a vaccine that so far has been linked to thousands of adverse events and at least 49 unexplained deaths. It’s a situation that the FDA and CDC have repeatedly denied, even as the adverse reports mount.
Gerberding’s 2004 report to Congress, ‘Prevention of Genital Human Papillomavirus Infection‘3 likely played a significant role in getting the controversial vaccine approved in the first place. Needless to say, the approval of this questionable vaccine guaranteed her future employer billions of dollars-worth of profits. Gerberding has also been a staunch defender of thimerosal, the mercury-based preservative used in many vaccines, and has consistently denied any links between vaccines and autism.
All in all, Gerberding has repeatedly demonstrated that safety is nowhere on her list of priorities or concerns when it comes to vaccines. It’s easy to see why Merck would want her to head up their vaccine unit. For the rest of us, however, her blatant disregard for proven vaccine safety is bad news indeed.
Former NIH Director Now Heads Sanofi Research Labs
Another former government official who’s switched sides is Elias Zerhouni, former director of the National Institutes of Health (NIH)—one of the world’s foremost medical research centers, and an agency of the US Department of Health and Human Services. Zerhouni is now head of Sanofi-Aventis’ research labs4. He also is a professor at Johns Hopkins School of Medicine; a member of the Board of Trustees at the Mayo Clinic; and is a senior fellow for the Bill & Melinda Gates Foundation’s Global Health Program5.
As pointed out in a recent article by Forbes Magazine6, Zerhouni is no stranger to controversies over conflicts-of-interest.
In the fall of 2003, the NIH with Zerhouni at its head faced grave accusations when it came to light that hundreds of its scientists had financial ties to the medical and pharmaceutical industries. According to a 2004 article in the NIH Record7, over 100 scientists did not get approval for their industry activities, even though the rules were so loose virtually all requests to conduct outside work were approved by the agency, without any limits on compensation or hours worked for outside entities.
In one case, an academic scientist was found to have a financial interest in a therapy that ended up killing a patient. The case served as a potent warning of how dangerous such conflicts of interest can be. While Zerhouni managed to emerge from the 2003 debacle looking like a good crisis manager, the following paragraphs from the NIH Record8 are quite telling. Essentially, Zerhouni dissuaded Congress from doing the right thing, which is ban all outside activities of those working for the NIH, limiting the restrictions for conflicts of interest to upper level management only:
“[Zerhouni] disclosed that “initially, Congress truly wanted to ban [all outside activities], and the members of the committee have been very public about that…I was fortunate to be able to make contact with legislators and to help them understand what happened, how it happened, and why [a draconian response] might not be the right thing to do.”
Zerhouni said that over the course of long discussion, a good consensus emerged that formed the basis of NIH’s approach to the issue: stewards of public funds should never be vulnerable even to the perception that their activities could result in private gain. The top concern, he said, is, “How do you keep a true firewall and separation between the public trust — the money the public has given us in trust — and the activities of those who manage that resource?”
He doesn’t think it was well appreciated outside of NIH that the agency “has a dual nature — number one, we are a granting agency, but number two, we are also one of the most advanced, most capable biomedical research institutions in the world.
So we’re both sort of an academic, scientific research place, and yet next to that we’re also a government agency with its own rules and regulations…I said, look, we need to build a firewall around those who have fiduciary responsibility relative to the government, and those who do not. And that’s where we came up with these much more stringent rules for directors, deputy directors, and people who have those authorities, versus those who do not.”
Conflicts of Interest Affect Your Life and Well-Being…
When it comes to medicine, mere disclosure of conflict of interest is not nearly enough. Patients need unbiased advice when it comes to making decisions that can impact their very life, and physicians and scientists with financial ties to the drug industry should not be allowed to participate in broad policy and public-health recommendations in the first place. Likewise, while it’s perfectly legal to engage the revolving door and switch jobs from government agencies to private industry and vice-versa, this practice has become so widespread it has undermined the entire system of checks and balances.
Conflict of interest is rampant not only within the field of medicine, but the revolving doors between government and industry has effectively led to a situation where it’s now extremely difficult, if not impossible, to trust conventional health advice from the federal government—which is supposed to be independent due to this massive collusion between government and industry. Here are a few more examples of the many revolving doors between the pharmaceutical industry and the US government:
- The American Cancer Society has close financial ties to both makers of mammography equipment and cancer drugs. Other conflicts of interest include ties to, and financial support from, the pesticide, petrochemical, biotech, cosmetics, and junk food industries—the very industries whose products are the primary contributors to cancer
- Drug companies pay seven-figure amounts into FDA coffers to gain approval of their drugs. FDA staff knows that the cash means higher salaries and more perks in the agency budget. (Incidentally, the FDA’s commissioner Margaret Hamburg came straight from the boardroom of America’s largest seller of dental amalgam, Henry Schein, Inc.)
- Conflicts of interest are also rampant in a mass vaccination infrastructure that has the same people who are regulating and promoting vaccines also evaluating vaccine safety.
- The vaccine industry gives millions for conferences, grants, and medical education classes sponsored by the American Academy of Pediatrics (AAP). The vaccine industry even helped build AAP’s headquarters.
- President Obama’s nominee at the Department of Homeland Security overseeing bioterrorism defense, Dr. Tara O’Toole, served as a key advisor for a lobbying group funded by a pharmaceutical company that asked the government to spend more money for anthrax vaccines and biodefense research9
There are countless others—so many, in fact, I’m sure you could fill an entire book with examples. These types of blatant conflicts should simply not be tolerated, but they most certainly are. For now the majority still does not understand the pharmaceutical industry’s power and influence over government, and the field of conventional medicine itself, but the tide is beginning to turn, and will continue to do so as more and more people get informed.
“Burgermeister presents evidence of acts of bioterrorism that is in violation of U.S. law by a group operating within the U.S. under the direction of international bankers who control the Federal Reserve, as well as WHO, UN and NATO. This bioterrorism is for the purpose of carrying out a mass genocide against the U.S. population by use of a genetically engineered flu pandemic virus with the intent of causing death. This group has annexed high government offices in the U.S.
Specifically, evidence is presented that the defendants, Barack Obama, President of the U.S, David Nabarro, UN System Coordinator for Influenza, Margaret Chan, Director-General of WHO, Kathleen Sibelius, Secretary of Department of Health and Human Services, Janet Napolitano, Secretary of Department of Homeland Security, David de Rotschild, banker, David Rockefeller, banker, George Soros, banker, Werner Faymann, Chancellor of Austria, and Alois Stoger, Austrian Health Minister, among others, are part of this international corporate criminal syndicate which has developed, produced, stockpiled and employed biological weapons to eliminate the population of the U.S. and other countries for financial and political gain.
The charges contend that these defendants conspired with each other and others to devise, fund and participate in the final phase of the implementation of a covert international bioweapons program involving the pharmaceutical companies Baxter and Novartis. They did this by bioengineering and then releasing lethal biological agents, specifically the “bird flu” virus and the “swine flu virus” in order to have a pretext to implement a forced mass vaccination program which would be the means of administering a toxic biological agent to cause death and injury to the people of the U.S. This action is in direct violation of the Biological Weapons Anti-terrorism Act.
Burgermeister’s charges include evidence that Baxter AG, Austrian subsidiary of Baxter International, deliberately sent out 72 kilos of live bird flu virus, supplied by the WHO in the winter of 2009 to 16 laboratories in four counties. She claims this evidence offers clear proof that the pharmaceutical companies and international government agencies themselves are actively engaged in producing, developing, manufacturing and distributing biological agents classified as the most deadly bioweapons on earth in order to trigger a pandemic and cause mass death.”
In short, while they are killing us deliberately, they are also profiting hugely from our controlled demise.
In our case, we have taken a proactive approach.
We have completely abandoned all drugs and haven’t gone to the drugstore for the last 7 years, or so, even if drugs are cheaper here than in the US.
We have been using electric current to kill all types of parasites, i.e. bacteria and viruses, to keep ourselves healthy all the time. The advantages are pretty clear:
- We don’t need to know the names and types of parasite we will be dealing with. All types of infection can be neutralized by the use of electric current;
- Every time there’s news about pandemic, we just charge the batteries up and use the gadgets. We don’t need to vaccinate beforehand, as the whole thing can be used on demand;
- … and the best part is that the whole system is a lot cheaper than one pill of Sovaldi!
Realizing that a low-voltage electric current can kill every parasite known and unknown including but not limited to, bacteria, viruses and fungus, in its proximity, for what do we need chemical drugs for?
Clearly, the emergence of drug resistant superbugs should render the mainstream medicine obsolete.